Ambulatory blood pressure monitoring and target organ damage in pediatrics

Journal of Hypertension

Volumn 25, Issue 10, 2007, Pages 1979-1986

  Stabouli, Stella ^a,b,d   Kotsis, Vasilios ^c   Zakopoulos, Nikos ^b  

^a P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d International Pediatric Hypertension Association (IPHA)   (Greece)

Author keywords

Ambulatory blood pressure monitoring; Blood pressure load; Blood pressure variability; Dipping; Intima media thickness; Left ventricular hypertrophy; Masked hypertension; White coat hypertension

Indexed keywords

AGE DISTRIBUTION; BLOOD PRESSURE MONITORING; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CAROTID ARTERY; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE; HEART RATE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN INJURY; POPULATION RESEARCH; PRIORITY JOURNAL; PULSE PRESSURE; REVIEW; SEX RATIO; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; WHITE COAT HYPERTENSION;

EID: 34748851934     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282775992     Document Type: Review

References (118)

1. American Academy of Pediatrics, National High Blood Pressure Educational Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114:555-576.
2. American Academy of Pediatrics, Committee on Nutrition. Prevention of pediatric overweight and obesity. Pediatrics 2004; 112:424-430.
3. Sorof JM, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension 2002; 40:441-447.
4. Stergiou GS, Yiannes NJ, Rarra VC, Alamara CV. White-coat hypertension and masked hypertension in children. Blood Press Monit 2005; 10:297-300.
5. Pall D, Katona E, Fulesdi B, Zrinyi M, Zatik J, Bereczki D, et al. Blood pressure distribution in a Hungarian adolescent population: comparison with normal values in the USA. J Hypertens 2003; 21:41-47.
6. Genovesi S, Giussani M, Pieruzzi F, Vigorita F, Arcovio C, Cavuto S, et al. Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight. J Hypertens 2005; 23:493-497.
7. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004; 113:475-482.
8. Jago R, Harrell SJ, McMurray GR, Edelstein S, El Ghormli L, Bassin S. Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics 2006; 117:2065-2073.
9. Muntner P, He J, Cutler JA, Wildman RP, Whelton PK. Trends in blood pressure among children and adolescents. JAMA 2004; 291:2107-2113.
10. Klumbiene J, Sileikiene L, Milasauskiene Z, Zaborskis A, Shatchkute A. The relationship of childhood to adult blood pressure: longitudinal study of juvenile hypertension in Lithuania. J Hypertens 2000; 18:531-538.
11. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens 1995; 8:657-665.
12. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338:1650-1656.
13. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intima-media thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 2001; 104:2515-2819.
14. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al., European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23:697-701.
15. Staessen JA, Asmar R, De Buyzere M, Imai Y, Parati G, Shimada K, et al. Participants of the 2001 Consensus Conference on Ambulatory Blood Pressure Monitoring. Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit 2001; 6:355-370.
16. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111:697-716.
17. Lurbe E, Thijs L, Redon J, Alvarez V, Tacons J, Staessen J. Diurnal blood pressure curve in children and adolescents. J Hypertens 1996; 14:41-46.
18. Gillman MW, Cook NR. Blood pressure measurement in childhood epidemiological studies. Circulation 1995; 92:1049-1057.
19. Sorof JM. White coat hypertension in children. Blood Press Monit 2000; 5:197-202.
20. Sorof JM, Portman RJ. Ambulatory blood pressure measurements. Curr Opin Pediatr 2001; 13:133-137.
21. Rocchini AP. Pediatric hypertension 2001. Curr Opin Cardiol 2002; 17:385-389.
22. Portman RJ, Yetman RJ, West MS. Efficacy of 24-h ambulatory blood pressure monitoring in children. J Pediatr 1991; 118:842-849.
23. Reusz GS, Hobor M, Tulassay T, Sallay P, Miltenyi M. 24 h blood pressure monitoring in healthy and hypertensive children. Arch Dis Child 1994; 70:90-94.
24. O'Sullivan JJ, Derrick G, Griggs P, Foxall R, Aitkin M, Wren C. Ambulatory blood pressure in schoolchildren. Arch Dis Child 1999; 80:529-532.
25. Gellermann J, Kraft S, Ehrich JH. Twenty-four-hour ambulatory blood pressure monitoring in young children. Pediatr Nephrol 1997; 11:707-710.
26. Varda NM, Gregoric A. Twenty-four-hour ambulatory blood pressure monitoring in infants and toddlers. Pediatr Nephrol 2005; 20:798-802.
27. Khan IA, Gajaria M, Stephens D, Balfe JW. Ambulatory blood pressure monitoring in children: a large center's experience. Pediatr Nephrol 2000; 14:802-805.
28. Stabouli S, Kotsis V, Papamichael C, Constantopoulos A, Zakopoulos N. Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. J Pediatr 2005; 147:651-656.
29. O'Brien E, Atkins N, Staessen J. Factors influencing validation of ambulatory blood pressure measuring devices. J Hypertens 1995; 13:1235-1240.
30. Belsha CW, Wells TG, Bowe Rice H, Neaville WA, Berry PL. Accuracy of the SpaceLabs 90207 ambulatory blood pressure monitor in children and adolescents. Blood Press Monit 1996; 1:127-133.
31. Goonasekera CD, Wade AM, Slattery M, Brennan E, Dillon MJ. Performance of a new blood pressure monitor in children and young adults: the difficulties in clinical validation. Blood Press 1998; 7:231-237.
32. O'Sullivan JJ, Derrick G, Griggs PE, Wren C. Validation of the Takeda 2421 ambulatory blood pressure monitor in children. J Med Eng Technol 1998; 22:101-105.
33. Lurbe E, Cremades B, Rodriguez C, Torro MI, Alvarez V, Redon J. Factors related to quality of ambulatory blood pressure monitoring in a pediatric population. Am J Hypertens 1999; 12:929-933.
34. Lurbe E, Redon J. Reproducibility and validity of ambulatory blood pressure monitoring in children. Am J Hypertens 2002; 15:69S-73S.
35. Rucki S, Feber J. Repeated ambulatory blood pressure monitoring in adolescents with mild hypertension. Pediatr Nephrol 2001; 16:911-915.
36. Stergiou GS, Alamara CV, Salgami EV, Vaindirlis IN, Dacou-Voutetakis C, Mountokalakis TD. Reproducibility of home and ambulatory blood pressure in children and adolescents. Blood Press Monit 2005; 10:143-147.
37. Flynn JT. Impact of ambulatory blood pressure monitoring on the management of hypertension in children. Blood Press Monit 2000; 5:211-216.
38. Graves JW, Althaf MM. Utility of ambulatory blood pressure monitoring in children and adolescents. Pediatr Nephrol 2006; 21:1640-1652.
39. Gavrilovici C, Goldsmith DJ, Reid C, Gubeth-Tatomir P, Covic A. What is the role of ambulatory BP monitoring in pediatric nephrology? J Nephrol 2004; 17:642-652.
40. American Academy of Pediatrics, National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996; 98:649-658.
41. Reichert H, Lindinger A, Frey O, Mortzeck J, Kiefer J, Busch C, et al. Ambulatory blood pressure monitoring in healthy schoolchildren. Pediatr Nephrol 1995; 9:282-286.
42. Diaz LN, Garin EH. Comparison of ambulatory blood pressure and Task Force criteria to identify pediatric hypertension. Pediatr Nephrol 2007; 22:554-558.
43. Kennedy SE, Mackie FE, Craig E, Kainer G. The choice of threshold limits for pediatric ambulatory blood pressure monitoring influences clinical decisions. Blood Press Monit 2006; 11:119-123.
44. Kennedy SE, Mackie FE, Rosenberg AR, Craig E, Kainer G. Agreement on reporting of ambulatory blood pressure monitoring in children. Pediatr Nephrol 2005; 20:1766-1768.
45. Lurbe E, Redon J, Liao Y, Tacons J, Cooper RS, Alvarez V. Ambulatory blood pressure monitoring in normotensive children. J Hypertens 1994; 12:1417-1423.
46. Harshfield GA, Alpert BS, Pulliam DA, Somes GW, Wilson DK. Ambulatory blood pressure recordings in children and adolescents. Pediatrics 1994; 94:180-184.
47. Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 1997; 130:178-184.
48. Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002; 20:1995-2007.
49. Verdecchia P, Clement D, Fagard R, Palatini P, Parati G. Blood pressure monitoring. Task force III: Target-organ damage, morbidity and mortality. Blood Press Monit 1999; 4:303-317.
50. Lurbe E, Sorof JM, Daniels SR. Clinical and research aspects of ambulatory blood pressure monitoring in children. J Pediatr 2004; 144:7-16.
51. Koshy S, Macarthur C, Luthra S, Gajaria M, Geary D. Ambulatory blood pressure monitoring: mean blood pressure and blood pressure load. Pediatr Nephrol 2005; 20:1484-1486.
52. Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 2002; 39:903-908.
53. Flynn JT. Differentiation between primary and secondary hypertension in children using ambulatory blood pressure monitoring. Pediatrics 2002; 110:89-93.
54. Lurbe E, Invitti C, Torro I, Maronati A, Aguilar F, Sartorio G, et al. The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens 2006; 24:1557-1564.
55. Parati G, Lantelme P. Blood pressure variability, target organ damage and cardiovascular events. J Hypertens 2002; 20:1725-1729.
56. Zakopoulos NA, Tsivgoulis G, Barlas G, Papamichael C, Spengos K, Manios E, et al. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005; 45:505-512.
57. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension: Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546.
58. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20:2183-2189.
59. Mitsnefes MM, Kimball TR, Daniels SR. Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol 2003; 18:145-149.
60. Wuhl E, Hadtstein C, Mehls O, Schaefer F, ESCAPE Trial Group. Ultradian but not circadian blood pressure rhythms correlate with renal dysfunction in children with chronic renal failure. J Am Soc Nephrol 2005; 16:746-754.
61. Amin RS, Carroll JL, Jeffries JL, Grone C, Bean JA, Chini B, et al. Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med 2004; 169:950-956.
62. Leung LC, Ng DK, Lau MW, Chan CH, Kwok KL, Chow PY, et al. Twenty-four-hour ambulatory BP in snoring children with obstructive sleep apnea syndrome. Chest 2006; 130:1009-1017.
63. Lurbe E, Redon J, Pascual JM, Tacons J, Alvarez V. The spectrum of circadian blood pressure changes in type I diabetic patients. J Hypertens 2001; 19:1421-1428.
64. Theochari MA, Vyssoulis GP, Toutouzas PK, Bartsocas CS. Arterial blood pressure changes in children and adolescents with insulin-dependent diabetes mellitus. J Pediatr 1996; 129:667-670.
65. Belsha CW, Wells TG, McNiece KL, Seib PM, Plummer JK, Berry PL. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens 1998; 11:410-417.
66. Sorof JM, Alexandrov A, Cardwell G, Portman RJ. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003; 11:61-66.
67. Flynn JT. What is the significance of increased carotid intima media thickness in hypertensive adolescents? Hypertension 2006; 48:23-24.
68. Daniels SR, Lipman MJ, Burke MJ, Loggie JM. Determinants of retinal vascular abnormalities in children and adolescents with essential hypertension. J Hum Hypertens 1993; 7:223-228.
69. Pose-Reino A, Gomez-Ulla F, Hayik B, Rodriguez-Fernandez M, Carreira-Nouche MJ, Mosquera-Gonzalez A, et al. Computerized measurement of retinal blood vessel calibre: description, validation and use to determine the influence of ageing and hypertension. J Hypertens 2005; 23:843-850.
70. Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998; 97:1907-1911.
71. Hanevold C, Waller J, Daniels S, Portman R, Sorof J, International Pediatric Hypertension Association. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 2004; 113:328-333.
72. Sorof JM, Turner J, Martin DS, Garcia K, Garami Z, Alexandrov AV, et al. Cardiovascular risk factors and sequelae in hypertensive children identified by referral versus school-based screening. Hypertension 2004; 43:214-218.
73. Kotsis V, Stabouli S, Pitiriga V, Papamichael C, Toumanidis S, Zakopoulos N. Impact of gender on 24-h ambulatory blood pressure and target organ damage. J Hum Hypertens 2006; 20:658-665.
74. Kotsis V, Stabouli S, Pitiriga V, Toumanidis S, Papamichael C, Zakopoulos N. Ambulatory blood pressure monitoring and target organ damage: effects of age and sex. Blood Press Monit 2006; 11:9-15.
75. Litwin M, Niemirska A, Sladowska J, Antoniewicz J, Daszkowska J, Wierzbicka A, et al. Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 2006; 21:811-819.
76. Harshfield GA, Pulliam DA, Alpert BS. Ambulatory blood pressure and renal function in healthy children and adolescents. Am J Hypertens 1994; 7:282-285.
77. De Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25:1056-1062.
78. Daniels SR, Meyer RA, Liang YC, Bove KE. Echocardiographically determined left ventricular mass index in normal children, adolescents and young adults. J Am Coll Cardiol 1988; 20:1251-1260.
79. Stabouli S, Kotsis V, Karagianni C, Toumanidis S, Constantopoulos A, Zakopoulos N. 24-h pulse pressure predicts left ventricular mass index in children and adolescents. J Hypertens 2007; 25 (Suppl 2):S297.
80. Jourdan C, Wuhl E, Litwin M, Fahr K, Trelewicz J, Jobs K, et al. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 2005; 23:1707-1715.
81. Sass C, Herbeth B, Chapet O, SiestG, Visvikis S, Zannad F. Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens 1998; 16:1593-1602.
82. Lande MB, Carson NL, Roy J, Meagher CC. Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study. Hypertension 2006; 48:40-44.
83. Litwin M, Trelewicz J, Wawer Z, Antoniewicz J, Wierzbicka A, Rajszys P, et al. Intima-media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol 2004; 19:767-774.
84. Kotsis VT, Pitiriga VCh, Stabouli SV, Papamichael CM, Toumanidis ST, Rokas SG, et al. Carotid artery intima-media thickness could predict the presence of coronary artery lesions. Am J Hypertens 2005; 18:601-606.
85. Kotsis VT, Stabouli SV, Papamichael CM, Zakopoulos NA. Impact of obesity in intima media thickness of carotid arteries. Obesity 2006; 14:1708-1715.
86. Mitsnefes MM. Cardiovascular disease in children with chronic kidney disease. Adv Chronic Kidney Dis 2005; 12:397-405.
87. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 2006; 149:671-675.
88. Calzolari A, Giordano U, Matteucci MC, Pastore E, Turchetta A, Rizzoni G, Alpert B. Hypertension in young patients after renal transplantation: ambulatory blood pressure monitoring versus casual blood pressure. Am J Hypertens 1998; 11:497-501.
89. Matteucci MC, Giordano U, Calzolari A, Turchetta A, Santilli A, Rizzoni G. Left ventricular hypertrophy, treadmill tests, and 24-h blood pressure in pediatric transplant patients. Kidney Int 1999; 56:1566-1570.
90. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR. Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation. Circulation 2004; 110:97-101.
91. Lama G, Tedesco MA, Graziano L, Calabrese E, Grassia C, Natale F, et al. Reflux nephropathy and hypertension: correlation with the progression of renal damage. Pediatr Nephrol 2003; 18:241-245.
92. Guntsche Z, Saravi FD, Reynals EA, Rauek B, Rauek M, Guntsche EM. Parental hypertension and 24 h-blood pressure in children prior to diabetic nephropathy. Pediatr Nephrol 2002; 17:157-164.
93. Ettinger LM, Freeman K, DiMartino-Nardi JR, Flynn JT. Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus. J Pediatr 2005; 147:67-73.
94. Matsuoka S, Kawamura K, Honda M, Awazu M. White coat effect and white coat hypertension in pediatrics patients. Pediatr Nephrol 2002; 17:950-953.
95. Sorof JM, Portmann RJ. White coat hypertension in children with elevated casual blood pressure. J Pediatr 2000; 137:493-497.
96. Sorof JM, Poffenbarger T, Franco K, Portman R. Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens 2001; 14:855-860.
97. Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N. White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol 2005; 20:1151-1155.
98. Angeli F, Verdecchia P, Gattobigio R, Sardone M, Reboldi G. White-coat hypertension in adults. Blood Press Monit 2005; 10:301-305.
99. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998; 98:1892-1897.
100. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 2001; 38:238-245.
101. Pierdomenico SD, Lapenna D, Bucci A, Di Iorio A, Neri M, Cuccurullo F, et al. Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension. Am J Hypertens 2004; 17:876-881.
102. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 2005; 45:203-208.
103. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens 2003; 17:811-817.
104. Zakopoulos N, Papamichael C, Papaconstantinou H, Dubbins PA, Burrell CJ, Lekakis J, et al. Isolated clinic hypertension is not an innocent phenomenon: effect on the carotid artery structure. Am J Hypertens 1999; 12:245-250.
105. Zakopoulos NA, Kotsis VT, Pitiriga VCh, Toumanidis ST, Lekakis JP, Nanas SN, et al. White-coat effect in normotension and hypertension. Blood Press Monit 2002; 7:271-276.
106. Muscholl MW, Hense HW, Brockel U, Doring A, Riegger GA, Schunkert H. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ 1998; 317:565-570.
107. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104:1385-1392.
108. Kotsis V, Stabouli S, Pitiriga V, Papamichael C, Toumanidis S, Zakopoulos N. Impact of white coat and masked hypertension on target organ damage. J Hypertens 2006; 24 (Suppl 6):S147.
109. Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N. Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension 2005; 45:602-607.
110. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002; 40:795-796.
111. Longo D, Dorigatti F, Palatini P. Masked hypertension in adults. Blood Press Monit 2005; 10:307-310.
112. Mallion JM, Baguet JP, Mancia G. European Society of Hypertension Scientific Newsletter: Clinical value of ambulatory blood pressure monitoring. J Hypertens 2006; 24:2327-2330.
113. Mallion JM, Clerson P, Bobrie G, Genes N, Vaisse B, Chatellier G. Predictive factors for masked hypertension within a population of controlled hypertensives. J Hypertens 2006; 24:2365-2370.
114. Matsuoka S, Awazu M. Masked hypertension in children and young adults. Pediatr Nephrol 2004; 19:651-654.
115. Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, et al. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension 2005; 45:493-498.
116. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131:564-572.
117. Bjorklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens 2004; 22:1691-1697.
118. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, et al. Prognosis of 'masked' hypertension and 'white-coat' hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46:508-515.